Single-Dose Study of MK-4250 Monotherapy in Anti-Retroviral Therapy-Naive, Human Immunodeficiency Virus (HIV)-1 Infected Participants (MK-4250-002)
Clinical trial NCT03351699 · COMPLETED
Trial details
- NCT number
- NCT03351699
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-01-18
- Primary completion
- 2018-11-02
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.